SELL TO SCIENTISTS.

Industry Profile

Drug Delivery Systems

Target researchers — Pharmaceutical scientists, chemical engineers, and biophysicists specializing in nanoparticle formulation, lipid-based delivery, polymer matrices, inhalation, transdermal, and implantable systems

Drug delivery companies extend the therapeutic window and improve bioavailability of existing and novel APIs through lipid nanoparticles, polymer hydrogels, inhalation devices, and targeted delivery platforms. University pharmaceutical sciences departments are prolific IP generators for oral bioavailability enhancement, mucosal delivery, and brain-targeted carriers.

$210B Market size
10 Key companies
6 Use cases

Key Companies

Catalent Lonza Drug Delivery Vectura Haleon NovaBay Pharmaceuticals Bend Research Capsugel Lonza Particle Sciences Evonik Drug Delivery Lubrizol Pharma Nuvax Pharma

Use Cases

01

Lipid nanoparticle formulation licensing

02

Inhalation device technology transfer

03

Controlled-release polymer IP licensing

04

Solubility enhancement consulting

05

Bioavailability improvement partnerships

06

CDMO formulation services

Free to browse · subscribe to unlock the full dataset

See the full dataset.

Create a free account to search every researcher, set alerts, and export verified contacts to CSV / API.

Sign Up Free →
Get Started